# Charles River Laboratories International, Inc. (CRL) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1100682). Listed on NYSE.
> Sector: Servicios de ingeniería · Industry: Services-Commercial Physical & Biological Research
> Canonical URL: https://cifraresearch.com/en/empresa/CRL

## Business Profile

Profile and analysis of Charles River Laboratories International, Inc. in the servicios de ingeniería sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Charles River Laboratories International, Inc. reported sales of 4015 M$, net income of -144 M$ and free cash flow (FCF) of 518 M$ (13% FCF margin) (diluted earnings per share of -2,91 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 4015 M$ | 25 M$ | -144 M$ | 518 M$ | -2,91 $ |
| 2024 | 4050 M$ | 227 M$ | 22 M$ | 502 M$ | 0,20 $ |
| 2023 | 4129 M$ | 617 M$ | 475 M$ | 365 M$ | 9,22 $ |
| 2022 | 3976 M$ | 651 M$ | 486 M$ | 295 M$ | 9,48 $ |
| 2021 | 3540 M$ | 590 M$ | 391 M$ | 532 M$ | 7,60 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1100682/000110068226000157/crl-20260926.htm) — Filed on 2026-11-04
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1100682/000110068226000118/crl-20260627.htm) — Filed on 2026-08-05
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1100682/000110068226000038/crl-20260328.htm) — Filed on 2026-05-07
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1100682/000110068226000022/crl-20251227.htm) — Filed on 2026-02-18
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1100682/000110068225000043/crl-20250927.htm) — Filed on 2025-11-05
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1100682/000110068225000034/crl-20250628.htm) — Filed on 2025-08-06
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1100682/000110068225000021/crl-20250329.htm) — Filed on 2025-05-07
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1100682/000110068225000011/crl-20241228.htm) — Filed on 2025-02-19

## Reports Analyzed with AI on Cifra

- [Report 10-K 2025 ANNUAL results — CRL](https://cifraresearch.com/informe/CRL/2025-10K) ([Markdown](https://cifraresearch.com/informe/CRL/2025-10K.md))
- [Report 10-Q 2026 Q3 results — CRL](https://cifraresearch.com/informe/CRL/2026-Q3) ([Markdown](https://cifraresearch.com/informe/CRL/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Charles River Laboratories International, Inc. operate in?
Charles River Laboratories International, Inc. (CRL) is listed on NYSE and operates in the Services-Commercial Physical & Biological Research industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for CRL?
In the official SEC EDGAR system under CIK 1100682 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/CRL).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.